Vaccination Not Needed for Patients with High IgG Antibodies to B. pertussis and Rubella
Patients with high IgG antibody levels against Bordetella pertussis and rubella do not need vaccination against these diseases, as these elevated antibody levels indicate immunity from prior infection or vaccination.
Understanding Immunity to Rubella
High levels of rubella IgG antibodies indicate immunity to rubella, which can be acquired through:
- Previous natural infection with rubella virus
- Previous vaccination with rubella-containing vaccine (usually MMR)
According to the Advisory Committee on Immunization Practices (ACIP), persons can be considered immune to rubella if they have:
- Laboratory evidence of rubella immunity (positive IgG antibodies) 1
- Documentation of adequate immunization with at least one dose of rubella vaccine on or after the first birthday 1
The presence of rubella-specific antibody detectable by any serologic test is considered evidence of immunity 1. When serum specimens show positive rubella IgG, the person should be considered immune, regardless of vaccination history 1.
Understanding Immunity to Bordetella pertussis
High levels of IgG antibodies against pertussis toxin (PT) are indicative of recent or active infection with Bordetella pertussis. Research has shown that:
- IgG-PT levels of at least 100 U/ml are diagnostic of recent or active infection with B. pertussis 2
- Such elevated levels are present in less than 1% of the general population 2
- These levels are typically reached within 4 weeks after disease onset and persist only temporarily 2
Clinical Decision Making
For Rubella:
- A positive rubella IgG antibody test indicates immunity and protection against future infection
- No additional vaccination is required when laboratory evidence of immunity exists 1
- The clinical diagnosis of rubella is unreliable and should not be considered in assessing immune status; only serologic evidence is reliable 1
For Bordetella pertussis:
- High IgG antibody levels against B. pertussis indicate recent infection and subsequent immunity
- While pertussis immunity can wane over time (5-10 years after vaccination or infection) 1, the presence of high antibody levels indicates current protection
Important Considerations
- Rubella immunity from vaccination appears to be long-term, probably lifelong 1
- Pertussis immunity can wane over time, but high antibody levels indicate current protection
- For immunocompromised patients, special considerations apply regarding live vaccines 1, but this doesn't appear relevant to the current case
Pitfalls to Avoid
Don't confuse equivocal results with positive results: Persons with "equivocal" rubella test results should be considered susceptible unless they have other evidence of immunity or subsequent testing indicates immunity 1
Don't assume clinical diagnosis is reliable: For rubella, clinical diagnosis is unreliable and should not be considered in assessing immune status 1
Don't ignore high pertussis antibody levels: High levels of IgG antibodies against pertussis toxin are diagnostic of recent infection and current immunity 2
Don't revaccinate unnecessarily: When laboratory evidence of immunity exists, revaccination is not necessary and provides no additional benefit while potentially exposing the patient to unnecessary vaccine side effects
In conclusion, based on the evidence provided, a patient with high IgG antibody levels to both B. pertussis and rubella has laboratory evidence of immunity to these diseases and does not require vaccination against them.